seed
Stage
1
Investors
About
Scripta Therapeutics is a techbio company that uses AI, imaging, and patient-derived models to create disease maps based on transcriptional networks, aiming to discover disease-modifying drugs that modulate transcription factor activity to restore healthy cell states, initially focusing on Alzheimer's disease and other neurodegenerative conditions.
Explore Scripta Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.